Caris Life Sciences, Inc. (CAI) — 10-Q Filings
All 10-Q filings from Caris Life Sciences, Inc.. Browse 2 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (2)
- 10-Q Filing — May 8, 2026
-
Caris Life Sciences Revenue Soars 84% Amid IPO Capital Infusion
— Nov 5, 2025 Risk: medium
Caris Life Sciences, Inc. reported a significant increase in total revenue for the nine months ended September 30, 2025, reaching $519.1 million, up from $282.3
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX